MARKET

NTRB

NTRB

Nutriband Inc
NASDAQ
4.800
+0.060
+1.27%
After Hours: 4.800 0 0.00% 16:10 12/26 EST
OPEN
4.650
PREV CLOSE
4.740
HIGH
4.910
LOW
4.640
VOLUME
12.83K
TURNOVER
--
52 WEEK HIGH
11.78
52 WEEK LOW
3.722
MARKET CAP
58.44M
P/E (TTM)
-1.5658
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NTRB last week (1215-1219)?
Weekly Report · 6d ago
Nutriband Inc. Announces Date for Upcoming Annual Meeting of Stockholders
Reuters · 12/19 16:02
Trump Trade: Trump Media to merge with TAE Technologies
TipRanks · 12/18 15:15
Nutriband signs LOI with Qvanta Group of companies
TipRanks · 12/18 13:05
Nutriband Signs LOI to Explore Quantum-AI Collaboration with Qvanta Group
Reuters · 12/18 13:02
NUTRIBAND INC. SIGNS LETTER OF INTENT WITH QVANTA GROUP OF COMPANIES TO EXPLORE ADVANCED TECHNOLOGY SOLUTIONS FOR ABUSE-DETERRENT PHARMACEUTICAL INNOVATION STRATEGIC EXPLORATION
Reuters · 12/18 13:00
Nutriband provides response to Trump’s Executive Order related to fentanyl
TipRanks · 12/18 12:10
Nutriband Responds To Executive Order Designating Illicit Fentanyl As A Weapon Of Mass Destruction, Differentiates Prescription Transdermal Fentanyl And Highlights Aversa Fentanyl Development
Benzinga · 12/18 12:07
More
About NTRB
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Webull offers Nutriband Inc stock information, including NASDAQ: NTRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTRB stock methods without spending real money on the virtual paper trading platform.